Johnson & Johnson's (JNJ) results show the firm's ability to offset generic and branded competition, says Damien Conover. He and David Toung recap JNJ's earnings. They talk about how the 4Q international sales came in at $11.19B and 4Q worldwide consumer sales came in at $3.77B. They then go over the key takeaways from JNJ's earnings. Tune in to find out more about the stock market today.
The Watch List
25 Jan 2023
SHARE
Market On Close
10 Nov 2023
Trading 360
13 Dec 2023
Market On Close
23 Jan 2024
Market On Close
01 Dec 2023
Trading 360
02 Nov 2023